Mega Biopharma

Mega Biopharma

MEGA BIOPHARMA is a French player in marine biotechnology, a pioneer in the development of Bionacre. This natural biomaterial extracted from mother-of-pearl has yielded scientifically proven results in terms in the domains of bone and skin repair. The company aims to offer innovative therapy solutions in several fields: dental surgery, orthopaedics, dermo-cosmetics, dermatology and veterinary care. Joel Drai then decided to set up MEGA BIOPHARMA, involving the dental surgeon twins in the venture. Ever since, the founding triumvirate has been determined to draw on these discoveries to design and develop medical devices and treatments to enhance the medicine of the future and yield benefits for the wider population.

Company details

16-18, rue des Investisseurs , Crosne , 91560 France
View in map

Find locations served, office locations

Business Type:
Manufacturer
Industry Type:
Medical Equipment
Market Focus:
Internationally (various countries)

The Doctors Camprasse are the inventors of our patented biomaterial Bionacre®, a sustainable innovation inspired by nature. 
Having been shell collectors since their early childhood, in 1982 they had an idea that they now describe as self-evident, even though the premise seemed crazy at first: what if the mother-of-pearl of a specific species of shellfish, which is ivory-coloured and harder than a bone, could be a substitute for it? They then embarked on research work which led them to make major discoveries, and which was the subject of a host of scientific publications as far back as the late 1980s.

When passionate biotechnologies enthusiast Joel Drai crossed paths with the Camprasse brothers in 2009, he was fascinated by their ingenuity and perseverance, and by their wealth of research work. He aligned himself with their vision: believing in the infinite potential of mother-of-pearl to treat beings.

Joel Drai then decided to set up MEGA BIOPHARMA, involving the dental surgeon twins in the venture. Ever since, the founding triumvirate has been determined to draw on these discoveries to design and develop medical devices and treatments to enhance the medicine of the future and yield benefits for the wider population.

The genesis of MEGA BIOPHARMA
1982

Start of research works by the Doctors Camprasse on mother-of-pearl.

1983

Invention of Bionacre® biomaterial
Proof of its safety and biocompatibility in respect of human subjects.

1985

Design of dental implant prototypes based on Bionacre®
Filing of the first patents – First clinical cases in humans

1988

First publications and conferences: emergence of international interest in mother-of-pearl and Bionacre® biomaterial

1989

Joel Drai set up MEGA INDUSTRIE, a group specialising in the distribution of dental and pharmaceutical products aimed at healthcare professionals

1991

Joel Drai set up MEGA DENTAL, specialising in the distribution of dental and orthodontic supplies, quickly becoming a market leader

2007

With a view to promoting innovation, MEGA INDUSTRIE developed MY PEARL , a manufacturer of a revolutionary dental alignment system, and FEEDJI, a platform to manage exchanges between dental surgeons and mutual insurance companies

Key dates in the MEGA BIOPHARMA story
2009

Decisive meeting of Joel Drai and the Doctors Camprasse, crystallising the setup of MEGA BIOPHARMA.

2010

Building of our R&D laboratory and production site, in Teloché (Le Mans). Structuring of the company, with the appointment of Dominique Gourmelen as CEO.

2015 - 2018

Studies and publications with Professor Chappard (GEROM CGU Angers) on sheep. Validation of the osseointegration and erodibility properties of mother-of-pearl.

Collaboration with BPI France to support MEGA BIOPHARMA in the development of its fundamental research and in the production of medical devices. Filing and registration of multiple patents (in France and beyond).

The clean room in Teloché (R&D and production)

2019

First capital raising through private investors

Development of the company via new appointments (Regulatory affairs, R&D, Product development, Marketing, Communication, Finance) and new collaborations (Doctor Marc Slama).

2020

Opening of the Paris office, development of commercial activity.

Building of our new R&D laboratory and production site, in Crosne.

Publication by the Doctors Camprasse, along with Professor Chappard, on the osseointegration and the erodibility of mother-of-pearl screws.

Expertise

Expertise in bone and skin repair and regeneration.
Multiples proofs of concepts and indexed critical clinical cases, along with multiple tests (in vivo, ex vivo, in vivo on animals), which have been the subject of scientific publications that are recognised by and the envy of the medical community.
38 years of fundamental and applied research.

Eco-responsibility

Our mother-of-pearl comes from Pinctada maxima, an oyster that’s found endemically on the island of Mauritius. This is exactly where we plan to farm it, and harvest it sustainably, on our own mollusc farms.
We will be opting for “clean” ingredients and environmentally-friendly packaging for our bone and skin repair medical devices, as well as for our dermocosmetic skincare products.

Innovation

Strong ambition in the health and skincare sectors.
A natural, ground-breaking, patented biomaterial: Bionacre®.
Unprecedented results.

Generosity

Towards humanity, the sea, the planet.
A laboratory dedicated to skin health and skincare.
Repairing living tissue whilst taking care of the environment.

Perseverance

38 years of research work for optimal results – we take the time to do things right. The development of safe, effective medical devices also calls for endurance: that’s our mission.

Humility

We may have a strong ambition and a powerful natural biomaterial, but our company remains a modest, manageably-sized one that acts with sincerity.